Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shane Cook

Hand Surgery Des Moines, IA Medical Doctor

NPI 1831483536 CMS profile 614873

1301 Pennsylvania Ave Ste 213, Des Moines, IA 50316

Open in the dashboard

General payments

$3,721

34 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shane Cook of Des Moines, IA is reported in the CMS Open Payments database as having received $3,721 across 34 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $258 7
2024 General $41 2
2023 General $131 3
2022 General $1,297 2
2021 General $48 3
2020 General $469 1
2019 General $1,476 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shane Cook
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Shane Cook were reported at $258. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Shane Cook Hand Surgery median Middle half National median
2019 $1,476 $383 $106–$1,905 $163
2020 $469 $172 $51–$1,268 $114
2021 $48 $263 $71–$1,591 $132
2022 $1,297 $336 $87–$1,938 $149
2023 $131 $233 $81–$1,114 $160
2024 $41 $258 $88–$1,203 $164
2025 $258 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Wardlow Enterprises $2,778 7 payments
  2. Arthrex, Inc. $356 10 payments
  3. AxoGen $292 3 payments
  4. Stryker Corporation $141 6 payments
  5. Integra LifeSciences Corporation $24 1 payment
  6. Smith+Nephew, Inc. $24 1 payment
  7. Pacira Pharmaceuticals Incorporated $23 1 payment
  8. PolyNovo North America LLC $21 1 payment
  9. Vertex Pharmaceuticals Incorporated $21 1 payment
  10. AbbVie, Inc. $18 1 payment
  11. Other $23 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $2,158 3 payments
  2. Food and Beverage $883 26 payments
  3. Travel and Lodging $680 5 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $180 2 payments
  2. DISTAL EXTREMITIES IMPLANTS COMPRESSION SCREWS METAL COMPRESSION SCREWS $94 1 payment
  3. PANGEA $42 2 payments
  4. VARIAX $34 1 payment
  5. T2 ALPHA $24 1 payment
  6. Integra Recon-Skin And Wound $24 1 payment
  7. Integra Recon-Skin And Wound $24 1 payment
  8. Integra Recon-Skin And Wound $24 1 payment
  9. INTEGRA DERMAL REGENERATION TEMPLATE $24 1 payment
  10. PRIMATRIX $24 1 payment
  11. Other $194 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

44

Median for Hand Surgery: 118

Drug cost

$356

Median for Hand Surgery: $615

Branded share of claims

50%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 22 $233
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 22 $123

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 114 billing codes

Paid by Medicare

$156,843

Of which drugs: $1,443

Medicare patients

412

Average age 74

Services billed

1,644

271 women, 141 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 61%
Depression 29%
Diabetes 28%
Chronic kidney disease 24%
Ischemic heart disease 22%
Osteoporosis 21%
Heart failure 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 93 287 $1,433

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record